A Beijing drug discovery company pairing deep learning for efficacy prediction, docking, and retrosynthesis with its own chemistry and animal labs.
Peking University Health Science Center / Beijing Gigaceuticals
Released June 17, 2021
Drug repurposing model that predicts a compound's L1000 transcriptional signature from SMILES and ranks it against a disease gene signature.